Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis

Author： Murdaca Giuseppe   Spanò Francesca   Puppo Francesco  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.6, 2013-11, pp. : 801-804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of TNF-α blocking agents in rheumatoid arthritis: an overview

By Toussirot Éric   Wendling Daniel  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 581-594

Informa Healthcare

Access to resources Recommend Favorite

TNF-α antagonists cost effective for rheumatoid arthritis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 538, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The therapeutic potential of TNF-α blockade in rheumatoid arthritis

By Paleolog Ewa  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 7, 2003-07 ,pp. : 1087-1095

Informa Healthcare

Access to resources Recommend Favorite

TNF- inhibitors and rheumatoid arthritis

By Shire M.G.   Muller G.W.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 5, 1998-05 ,pp. : 531-544

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide: A Review of its Use in Active Rheumatoid Arthritis

By Prakash A.   Jarvis B.  

Drugs, Vol. 58, Iss. 6, 1999-12 ,pp. : 1137-1164

Adis International

Access to resources Recommend Favorite